| 英文摘要 |
In order to implement the life-cycle management of medicinal products and effectively ensure the safety, efficacy, and quality of medicinal products, TFDA proactively improved management regulations, joined international organizations, and builds a regulatory environment that was in line with international standards. In the meantime, TFDA continue to improve drug registration and review mechanisms, drug distribution practices, digital management, quality and safety surveillances, and testing and analysis technology. Thus to strengthen drug risk management and hence provide a safe environment for the public, as well as facilitate the development of the domestic pharmaceutical industry. |
本站僅提供期刊文獻檢索。
